Plasma calprotectin was associated with platelet activation and no-reflow phenomenon in acute coronary syndrome

BACKGROUND: No-reflow occurs in 3–4% of all percutaneous coronary interventions (PCIs) and has a strong negative impact on clinical outcomes of acute coronary syndrome (ACS). Therefore, the discovery of a biomarker that can early predict the occurrence of no-reflow has great clinical significance. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Nian-Peng, Zhen, Xiao-Wen, Li, Liu-dong, Zhong, Lin, Wang, Hua, An, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547482/
https://www.ncbi.nlm.nih.gov/pubmed/33036574
http://dx.doi.org/10.1186/s12872-020-01717-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547482/
https://www.ncbi.nlm.nih.gov/pubmed/33036574
http://dx.doi.org/10.1186/s12872-020-01717-5

Ejemplares similares